FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to compositions of traditional Chinese medicine for the prevention or treatment of elevated blood lipid levels, elevated triglyceride levels, elevated cholesterol levels, hyperlipidemia and atherosclerosis. A traditional Chinese medicine composition for the prevention or treatment of elevated blood lipid levels, elevated triglyceride levels, elevated cholesterol levels, hyperlipidemia and atherosclerosis, wherein the traditional Chinese medicine composition is prepared from the following raw materials, in the following parts by weight: 20–30 parts of Scutellaria root, 10–20 parts of unripe orange fruit, 5–15 parts of rhubarb root, 5–10 parts of Baikal skullcap root, 5–15 parts of white peony root, 5–10 parts of dried ginger rhizome, 7–15 parts of leeches, 5–15 parts of licorice root, 5–15 parts of dried codonopsis root, 5–15 parts of Atractylodes macrocephala rhizome and 10–20 parts of pinellia tuber. A traditional Chinese medicine composition for the prevention or treatment of elevated blood lipids, elevated triglycerides, elevated cholesterol, hyperlipidemia and atherosclerosis, wherein the traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 20–30 parts of Bupleurum root, 10–20 parts of unripe orange fruit, 5–15 parts of rhubarb root, 5–10 parts of Baikal skullcap root, 5–15 parts of white peony root, 5–10 parts dried ginger rhizome, 7–15 parts leeches, 5–15 parts of licorice root, 5–15 parts of dried codonopsis root, 5–15 parts of Atractylodes macrocephala rhizome, 10–20 parts of pinelli tuber and 10–35 parts of oyster shell. A traditional Chinese medicine composition for the prevention or treatment of elevated blood lipid levels, elevated triglyceride levels, elevated cholesterol levels, hyperlipidemia and atherosclerosis, wherein the traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 20–30 parts of Bupleurum root, 10–20 parts of unripe orange fruit, 5–15 parts of rhubarb root, 5–10 parts of Baikal skullcap root, 5–15 parts of white peony root, 5–10 parts of dried ginger rhizome, 7–15 parts of leeches, 5–15 parts of licorice root, 5–15 parts of dried codonopsis root, 5–15 parts of Atractylodes macrocephala rhizome, 10–20 parts of pinellia tuber, 10–35 parts of oyster shell and 5–12 parts of red fermented rice.
EFFECT: above-described compositions are effective for the prevention or treatment of elevated blood lipids, elevated triglycerides, elevated cholesterol, hyperlipidemia and atherosclerosis.
8 cl, 8 dwg, 15 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION BASED ON MEDICINAL MATERIALS OF TRADITIONAL CHINESE MEDICINE FOR TREATMENT OF METABOLIC SYNDROME, ITS PRODUCTION METHOD AND USE, AND PHARMACEUTICAL DRUG BASED ON IT AND ITS USE | 2019 |
|
RU2780451C1 |
| REMEDY WITH ANTI-TUMOR EFFECT FOR TREATMENT OF ONCOLOGICAL DISEASES | 2018 |
|
RU2761429C2 |
| MEDICAMENT FOR TREATMENT OF HYPERKERATOSIS, INGROWN NAIL AND FOR HYGIENIC TREATMENT OF NAILS DEFORMED AFTER TRAUMA AND/OR AGING CHANGE | 2005 |
|
RU2292879C2 |
| N-ACYL DERIVATIVES OF AMINOACIDS, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION AND APPLICATION AS HYPOLIPIDEMIC PREPARATIONS | 2005 |
|
RU2335495C2 |
| HYPOLIPIDEMIC PHYTOAGENT | 2013 |
|
RU2553309C2 |
| METHODS FOR USE OF TRIACETYL-3-HYDROXYPHENYLADENOZINE IN TREATMENT OF INFLAMMATORY PROCESSES IN VESSELS OR IMPROVEMENT OF VESSEL ENDOTHELIUM FUNCTIONS | 2017 |
|
RU2783498C2 |
| DIETARY SUPPLEMENT AND METHOD FOR ITS PRODUCTION | 2023 |
|
RU2825783C1 |
| METHOD FOR SIMULATING IMMUNE-DEPENDENT ALLOGENIC PREGNANCY LOSS IN LABORATORY MICE | 2012 |
|
RU2511107C1 |
| 2-ETHYL-6-METHYL-3-HYDROXYLIRIDINIUMHYDROXYBUTANEDIOAT EXPRESSING ANTI-ISHEMIC, CEREBROPROTECTIVE, NEUROTROPIC AND LIPID-REGULATING ACTIVITY, PHARMACEUTICAL COMPOSITIONS AND MEDICAL PRODUCT | 2008 |
|
RU2377237C1 |
| METHOD OF SIMULATING ATHEROSCLEROSIS | 2012 |
|
RU2500041C1 |
